Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for women struggling with repeated miscarriages

NCT ID NCT06652113

Summary

This study is testing whether adding the medication hydroxychloroquine to standard thyroid hormone treatment helps women with recurrent pregnancy loss have successful pregnancies. Researchers will compare the two-drug combination against thyroid hormone treatment alone in nearly 800 women. The goal is to see if the combination improves the chance of having a live birth.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PREGNANCY LOSS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Sun Yat-Sen Memorial Hospital

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510120, China

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.